The double blind randomized comparative study of MRQ-01 in the cancer patients with breakthrough pain.
Phase of Trial: Phase III
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Maruishi Pharmaceutical
- 07 Apr 2017 Status changed from recruiting to completed.
- 07 Jul 2016 Planned End Date changed from 30 Sep 2016 to 31 Mar 2017.
- 15 Jun 2016 New trial record